BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Interleukin Genetics Inc. 

100 N. E. Loop 410
Suite 820
San Antonio  Texas  78216  U.S.A.
Phone: 210-349-6400 Fax: 210-384-3356


SEARCH JOBS








 Company News
Interleukin Genetics Inc. (ILGN) Reports First Quarter 2013 Financial Results 5/15/2013 7:48:55 AM    More...
Interleukin Genetics Inc. (ILGN) and University of North Carolina Publish Genetic Factors Predictive of Progression of Knee Osteoarthritis 5/8/2013 10:47:50 AM    More...
Interleukin Genetics Inc. (ILGN) Reports Fourth Quarter and Year End 2012 Financial Results 3/29/2013 6:22:39 AM    More...
Interleukin Genetics Inc. (ILGN) and Renaissance Health Service Corporation Enter Into a Preferred Participation Agreement for PST® Genetic Test 3/5/2013 9:52:26 AM    More...
Interleukin Genetics Inc. (ILGN) Reports Third Quarter 2012 Financial Results 11/15/2012 9:43:46 AM    More...
Interleukin Genetics Inc. (ILGN) Announces Conference Call to Discuss Third Quarter 2012 Results 11/6/2012 8:44:39 AM    More...
Interleukin Genetics Inc. (ILGN) Appoints Kenneth S Kornman as CEO and Director Succeeding Lewis H Bender 8/24/2012 9:00:41 AM    More...
Interleukin Genetics Inc. (ILGN) Reports Second Quarter 2012 Financial Results 8/15/2012 8:41:49 AM    More...
Interleukin Genetics Inc. (ILGN) Announces Conference Call to Discuss Second Quarter 2012 Results 8/7/2012 9:58:08 AM    More...
Interleukin Genetics Inc. (ILGN) Completes $3,000,000 Private Placement with Its Strategic Partner, Delta Dental Plan of Michigan 7/2/2012 10:13:37 AM    More...
12345678910...